Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease. uri icon

authors

  • Assunção, Sheila Seleri
  • Reisa Sperling, MD
  • Ritchie, Craig
  • Kerwin, Diana R
  • Aisen, Paul S
  • Lansdall, Claire
  • Atri, Alireza
  • Cummings, Jeffrey

publication date

  • January 1, 2022